Back to YC Companies

    Ångström AI

    Summer 2024
    Active

    Gen AI molecular simulations that reproduce wetlab results

    5 people View on YC

    Ångström AI at a glance

    Y Combinator batch
    Summer 2024
    Status
    Active
    Industry
    Healthcare
    Team size
    5 people
    Location
    Not recorded
    Website
    Not recorded

    Every field above comes from the Y Combinator company record. Nothing is estimated.

    Compare Ångström AI with similar YC companies →

    About Ångström AI

    Angstrom AI builds GenAI-based molecular simulations to substitute wet lab experiments in the pre-clinical drug development pipeline. We are a team of 2 PhD's and 2 Professors from the University of Cambridge who decided to start a company together after we realised how to combine breakthoughs in our research in quantum-accurate models of physics and generative AI models. Our Biotech/Pharma clients can verify the efficacy and safety of new drug candidates using our computer simulations, which match the accuracy of wet lab experiments, but are over 100x faster. We achieve this accuracy by constraining our genAI-based simulations to obey the laws of physics, avoiding the hallucinations seen in other GenAI technologies. Since joining YC, Angstrom AI has developed the first physically accurate gen-AI based simulation of multiple molecules interacting. We have published the first molecule water solubility results with accuracy within the error range of wet lab experiments. We have also kicked-off a 150K pilot project with a pharma company to apply our tech to estimating solubility in their drug development pipeline.

    Tags:
    AI-powered Drug Discovery
    Biotech
    Drug discovery
    AI